The Perfect Cd335 (nkp46) Monoclonal Antibody (9e2), Novafluor™ Blue 660-120s Holiday Edition [wvh2FnXo]

CD335 (NKp46) Monoclonal Antibody (9E2)

The CD335 (NKp46) Monoclonal Antibody (9E2) is a powerful tool for researchers investigating the role of NK cells in immune responses and diseases. This antibody specifically targets human CD335, also known as NKp46, a crucial molecule expressed on NK cells. As a member of the natural cytotoxicity receptor family, CD335 plays a pivotal role in activating and expanding resting NK cells, thereby eliminating tumor and virus-infected cells, including those infected with influenza. The 9E2 antibody has been reported to induce cytotoxicity, making it a valuable asset in various research applications.

Product Features and Specifications

This monoclonal antibody is conjugated with NovaFluor™ Blue 660-120S, offering exceptional fluorescence properties for high-resolution imaging. The NovaFluor dye is based on Phiton™ technology, ensuring engineered fluorescent signatures with minimized spillover and spread. The antibody has been pre-titrated and tested for flow cytometric analysis, providing convenient and consistent results. Key features include:

• High Specificity: The 9E2 antibody binds specifically to human CD335/NKp46, ensuring accurate detection.
• High Sensitivity: The antibody is highly sensitive, allowing for the detection of low-level expression of CD335/NKp46.
• Convenience: Pre-titrated and tested for flow cytometric analysis, saving time and effort in the lab.

Applications and Benefits

The CD335 (NKp46) Monoclonal Antibody (9E2) is ideal for a wide range of applications, including flow cytometric analysis. Its ability to induce cytotoxicity makes it particularly useful in studies involving NK cell activation and tumor cell killing. Key applications include:

• Immune Research: Investigating the role of NK cells in immune responses and diseases, such as type 1 diabetes.
• Cancer Research: Studying tumor cell killing and the potential of NK cells as a therapeutic strategy.
• Diabetes Research: Understanding the interaction between CD335/NKp46 and pancreatic beta cells in the development of type 1 diabetes.